Sputnik V vaccine production factory to be built in Vietnam in one year
A factory producing Russia’s Sputnik V vaccine against COVID-19 will be built in Vietnam within one year and is expected to produce 30-40 million doses annually, Chairman of Russian pharmaceutical company Binnopharm Dmitry Zubov told Vietnam News Agency correspondents in Russia.
Moscow (VNA) - A factory producing Russia’s Sputnik V vaccineagainst COVID-19 will be built in Vietnam within one year and is expected toproduce 30-40 million doses annually, Chairman of Russian pharmaceuticalcompany Binnopharm Dmitry Zubov told Vietnam News Agency correspondents inRussia.
Earlier this month, Binnopharm and the Russian DirectInvestment Fund signed a memorandum of understanding with Vietnam’s T&T Groupon the transfer of production technology and the formation of a facility with full cycle production capacity of Sputnik V COVID-19 vaccine inVietnam.
Chairman of Russian pharmaceutical company Binnopharm Dmitry Zubov (Photo: VNA)
According to Zubov, the time of one year for construction isfeasible, as Binnopharm has just built another factory in Belarus in eightmonths.
He said this will be a multi-purpose and closed-cyclefactory using advanced German equipment. It can produce other vaccines as well.
He considers this an important basis for Russia tostrengthen cooperation with Vietnam on pharmaceuticals, thereby entering theSoutheast Asian market./.
The Health Ministry’s Company for Vaccine and Biological Production No.1 (Vabiotech) announced on September 24 that it has successfully produced the first batch of Sputnik V vaccine in Vietnam.
Representatives from Russian and Vietnamese businesses operating in the field of pharmacy and health care exchanged experience and sought technological cooperation opportunities in the fight against COVID-19 at a round-table in Moscow on November 11.
Vietnamese pharmaceutical company VABIOTECH and Sovico Group signed a cooperation agreement with Russian Direct Investment Fund (RDIF) on the supply and production of Sputnik V COVID-19 vaccine in Vietnam in Moscow on December 2 with the witness of President Nguyen Xuan Phuc.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Sputnik V vaccine (Photo: AFP/VNA)
Chairman of Russian pharmaceutical company Binnopharm Dmitry Zubov (Photo: VNA)
